News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Dasatinib 50 mg daily is as effective and less toxic than 100 mg daily for newly diagnosed CML-CP
Photo of Dr. Hagop Kantarjian from obroncology.com
Jun 16, 2023, 19:38

Dasatinib 50 mg daily is as effective and less toxic than 100 mg daily for newly diagnosed CML-CP

In a post by Hagop Kantarjian on Twitter, it says, “Dasatinib 50 mg daily is as effective and less toxic than 100 mg daily for newly diagnosed CML-CP Georgina Gener-Ricos”

Article Link

Source: Hagop Kantarjian/Twitter

 

Dasatinib 50 mg daily is as effective and less toxic than 100 mg daily for newly diagnosed CML-CPDasatinib 50 mg daily is as effective and less toxic than 100 mg daily for newly diagnosed CML-CP

 

Dasatinib Georgina Gener-Ricos Hagop Kantarjian
Special Coverage
Insight
Dec 30, 2024, 12:33
Patrick Hwu: Why treating neurological disorders like brain tumors is difficult
Insight
Dec 30, 2024, 12:29
Laura Bukavina: No significant link was found between plant-based or animal-based protein intake and bladder cancer risk
Science
Dec 30, 2024, 12:25
Radical Prostatectomy Versus Stereotactic Radiotherapy for Clinically Localised Prostate Cancer
Science
Dec 30, 2024, 12:08
Nicholas Short: Measurable residual disease monitoring in AML
Blog
Dec 30, 2024, 12:06
Michael Hofman: Honoring Felix Feng
Science
Dec 30, 2024, 12:03
Misty Dawn Shields: Rare lung cancers have a paucity of info and they aren’t in first place
Science
Dec 30, 2024, 11:56
Anirban Maitra: The highest cited publication overall is a review on Pancreatic Cancer
Insight
Dec 30, 2024, 11:25
Shane Jacobson: The V Foundation is launching a search for Senior (executive) Leadership Team
Insight
Dec 30, 2024, 11:19
Anirban Maitra: An Open Access review on current status of KRAS inhibitors, resistance drivers and potential combinations
Insight
Dec 30, 2024, 11:16
Filippo Alongi: Analysis of patients with locally advanced rectal cancer given neoadjuvant radiochemotherapy with or without RT dose intensification
Societies
Dec 30, 2024, 10:56
“QI Scholar Nursing Presentations Part 1” from the SIOP Nursing Network
Insight
Dec 30, 2024, 10:54
Raul Cordoba: Early progression beyond first-line chemoimmunotherapy in follicular lymphoma by Alberto Bavieri et al.